Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
0.8400
-0.0100 (-1.18%)
May 26, 2026, 12:42 PM EDT - Market open
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $6.84 million as of May 26, 2026. Its market cap has increased by 11.24% in one year.
Market Cap
6.84M
Enterprise Value
6.91M
1-Year Change
11.24%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $6.84M, a decrease of -98.35%. That is a compound annual growth rate of -42.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 6.92M | -19.81% |
| Dec 31, 2025 | 8.63M | -45.03% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Liminatus Pharma | 7.60M |
| Immuron | 7.50M |
| Evogene | 7.46M |
| Acurx Pharmaceuticals | 7.23M |
| Can-Fite BioPharma | 7.05M |
| Processa Pharmaceuticals | 7.05M |
| Addex Therapeutics | 7.00M |
| Xenetic Biosciences | 6.94M |